JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 110 from EUR 105 and keeps a Neutral rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Sanofi Ends E.coli Vaccine Trial Amid Efficacy Concerns
- Senate votes to confirm Robert Kennedy as head of HHS
- Sanofi Launches €5 Billion Share Buyback Program
- Trump Trade: President advocates to close carried interest tax loophole
- White House readying order to fire thousands of federal health workers, WSJ says